翻訳と辞書
Words near each other
・ Odomez
・ Odomsith Singlatsomboun
・ ODON
・ Odon
・ Odon (river)
・ Odon Bacqué
・ Odon de Bénac
・ Odlew Poznań
・ Odlezly Lake
・ Odludek
・ Odlum
・ Odlum Brown Vancouver Open
・ Odlums Group
・ Odlyzko–Schönhage algorithm
・ ODM
ODM-201
・ ODMA
・ ODMA (disambiguation)
・ Odmar Færø
・ Odmark
・ Odmdenia
・ Odmieńce
・ ODMR
・ ODMRP
・ Odmy
・ Odmęt
・ ODN
・ Odna Zhizn
・ Odnes
・ Odness


Dictionary Lists
翻訳と辞書 辞書検索 [ 開発暫定版 ]
スポンサード リンク

ODM-201 : ウィキペディア英語版
ODM-201

ODM-201 (also known as BAY-1841788) is a non-steroidal antiandrogen, specifically, a full and high-affinity antagonist of the androgen receptor (AR), that is under development by Orion and Bayer HealthCare() for the treatment of advanced, castration-resistant prostate cancer (CRPC).
Relative to enzalutamide (MDV3100 or Xtandi) and apalutamide (ARN-509), two other recent non-steroidal antiandrogens, ODM-201 shows some advantages.〔 ODM-201 appears to negligibly cross the blood-brain-barrier.〔 This is beneficial due to the reduced risk of seizures and other central side effects from off-target GABAA receptor inhibition that tends to occur in non-steroidal antiandrogens that are structurally similar to enzalutamide.〔 Moreover, in accordance with its lack of central penetration, ODM-201 does not seem to increase testosterone levels in mice or humans, unlike other non-steroidal antiandrogens.〔 Another advantage is that ODM-201 has been found to block the activity of all tested/well-known mutant ARs in prostate cancer, including the recently-identified clinically-relevant F876L mutation that produces resistance to enzalutamide and ARN-509.〔 Finally, ODM-201 shows higher affinity and inhibitory efficacy at the AR (Ki = 11 nM relative to 86 nM for enzalutamide and 93 nM for ARN-509; IC50 = 26 nM relative to 219 nM for enzalutamide and 200 nM for ARN-509) and greater potency/efficaciousness in non-clinical models of prostate cancer.〔
ODM-201 has been studied in phase I and phase II clinical trials and has thus far been found to be effective and well-tolerated, with the most commonly reported side effects including fatigue, nausea, and diarrhea. No seizures have been observed.〔 As of July 2015, ODM-201 is in phase III trials for CRPC.〔
ORM-15341 is the main active metabolite of ODM-201.〔 It, similarly, is a full antagonist of the AR, with an affinity (Ki) of 8 nM and an IC50 of 38 nM.〔
==See also==

* Apalutamide
* EPI-001
* Galeterone
* Orteronel
* Abiraterone acetate
* VT-464

抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)
ウィキペディアで「ODM-201」の詳細全文を読む



スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース

Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.